EN
HI
Summary
As of 5 Oct, 2026, Aspira Pathlab & Diagnostics stock price is ₹125.1. During the trading session, the stock has moved between an intraday low of ₹125.10 and an intraday high of ₹131.25. Over the last 52 weeks, Aspira Pathlab & Diagnostics has traded between ₹49.00 and ₹149.99.
The stock has recorded a trading volume of 575 shares,. Its Average Traded Price (ATP) is ₹125.83, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 482 @ ₹125.10.
Aspira Pathlab & Diagnostics has an upper circuit limit of ₹137.80 and a lower circuit limit of ₹124.70. The total value traded stands at ₹72352.25, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Aspira Pathlab & Diagnostics also offers a dividend yield of 0%.
Aspira Pathlab & Diagnostics Share Price Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
575.00
Market Cap
128.77 CR
LTQ@LTP
482@125.10
ATP
125.83
Var Margin
100 %
Circuit Range
124.7-137.8
Delivery %
100 %
Value
72352.25
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Fundamentals
P/E Ratio
56.31
P/B Ratio
10.69
Div. Yield
0
Sector P/E
55.32
Sector P/B
-13.72
Sec. Div. Yield
0.18
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 135.42
Resistance
First Resistance
139.84
Second Resistance
148.42
Third Resistance
152.84
Support
First Support
126.84
Second Support
122.42
Third Support
113.84
Aspira Pathlab & Diagnostics Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 05 2026 | 131.25 | 125.1 | -4.69% | 131.25 | 125.1 |
| Thu Oct 01 2026 | 144 | 131.25 | -4.73% | 144 | 131 |
| Wed Sep 30 2026 | 149.97 | 137.77 | -3.88% | 149.99 | 136.36 |
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-12 | Others |
| 2026-08-12 | Quarterly Results & Raising of funds |
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30_Constitution Of Right Issue Committee
Aspira Pathlab's board approved raising funds not exceeding Rs. 65 crore through a Rights Issue to eligible equity shareholders. A Right Issue Committee has been constituted to finalize the terms and conditions, including the record date and issue price.
Sep 12 2026 16:57:53
Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Raising of Funds
Aspira Pathlab board has approved a rights issue to raise funds not exceeding Rs. 65 crore. This capital will be raised from eligible equity shareholders, subject to shareholder and regulatory approvals. A committee has been constituted to finalize the terms and conditions of the issue, including record date and price.
Sep 12 2026 16:52:24
Read More
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Auro Laboratories Ltd.
230.85
-12.95 (5.31%)
Smruthi Organics Ltd.
156.60
2.00 (1.29%)
Samrat Pharmachem Ltd.
240.65
7.80 (3.35%)
Lotus Eye Hospital And Institute Ltd.
114.60
-0.35 (0.30%)
Lasa Supergenerics Ltd.
5.39
0.00 (0.00%)
Star Imaging and Path Lab Ltd.
75.00
0.49 (0.66%)
Parnax Lab Ltd.
115.00
0.00 (0.00%)
Raaj Medisafe India Ltd.
101.45
2.99 (3.04%)
Alpa Laboratories Ltd.
59.55
-0.44 (0.73%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 125.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 56.31. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 10.69. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 55.32 & -13.72 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 128.77 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 149.99 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASPIRA
